This review will give an overview of recent advances in HMGB-1 in diabetes, diabetic cardiovascular complications, diabetic nephropathy (DN), and diabetic retinopathy (DR), and then we will focus on therapeutic strategies targeting HMGB-1. The gene discussed is HMGB1; the disease is diabetic retinopathy.